Edgewater Announces the Acquisition of MEDS, a Leading Patient Eligibility Services Provider
Edgewater Growth Capital Partners III is pleased to announce the recent acquisition of Monti Eligibility and Denial Solutions, Inc. and the Monti Group, Inc., collectively called MEDS (“MEDS” or the “Company”). MEDS is an outsourced provider of patient eligibility, enrollment and revenue recovery services to hospitals and health systems. MEDS customers are located primarily in Florida with additional operations in Indiana and Ohio.
MEDS is the first acquisition completed by our newly formed portfolio company Bolder Healthcare Solutions LLC (“BHS”). The ever-increasing complexity of the U. S. health care system is requiring greater expertise for health care providers to receive full payment for the services they render to patients, whether paid through private insurance or government programs. BHS has been created to provide these specialized services to health care providers to improve the performance of their revenue cycle and cash flow. BHS will strategically acquire key companies to bring together best of breed products and technologies to provide revenue cycle solutions for both hospitals and physician groups.
Edgewater is partnering with Michael Shea who is Chief Executive Officer of BHS. Mr. Shea was previously the founder and CEO of MedAssist, an innovator and leader in patient eligibility and other revenue cycle services. Edgewater and the BHS team under Mr. Shea’s leadership are actively engaged in additional acquisition activities.